Zager R A
Department of Medicine, University of Washington, Seattle.
Lab Invest. 1990 Sep;63(3):360-9.
Hyperthermia (39.5 degrees C) worsens experimental ischemic acute renal failure (ARF). We assessed whether it does so by affecting the ischemic and/or reperfusion injury phase and if its influence is mediated through changes in kidney ATP content and xanthine oxidase-mediated oxidant stress. Rats were subjected to 25 minutes of renal pedicle occlusion and hyperthermia was imposed during ischemia alone, reflow alone (0 to 30, 30 to 60, and 60 to 90 minutes), ischemia + reflow, or without ischemia. Hyperthermia's effects on ischemic/reperfusion adenylate pools lipid peroxidation (malondialdehyde), and the severity of ARF were assessed in comparison with normothermic ischemic controls. Hyperthermia confined to ischemia profoundly worsened ARF whereas during immediate reflow (0 to 30 minutes) hyperthermia had only a mild ARF-potentiating effect. During late reflow (greater than 30 minutes) or in the absence of ischemia, hyperthermia caused no damage. Hyperthermia had only a brief negative impact on ischemic ATP content, just slightly lowering it during the first 5 minutes of ischemia. Nevertheless, much greater ischemic damage resulted, reflected by increased proximal tubular brush border membrane sloughing at the end of vascular occlusion. Hyperthermia imposed only during reflow did not affect ATP concentrations. Hyperthermia increased end-ischemic purine base concentrations by 10% due to increased ATP degradation. However, reperfusion lipid peroxidation did not result and xanthine oxidase inhibition (by oxypurinol) conferred no protection.
(a) Hyperthermia worsens ARF predominantly by affecting ischemic, not reperfusion, injury; (b) xanthine oxidase is not an important mediator of hyperthermic-ischemic ARF; and (c) hyperthermia has a quantitatively trivial impact on ischemic ATP levels. This suggests that hyperthermia principally worsens ARF by magnifying the consequences of energy depletion (e.g., membrane damage) more than by worsening energy depletion, per se.
高热(39.5摄氏度)会加重实验性缺血性急性肾衰竭(ARF)。我们评估了高热是否通过影响缺血和/或再灌注损伤阶段来加重ARF,以及其影响是否通过肾脏ATP含量的变化和黄嘌呤氧化酶介导的氧化应激来介导。对大鼠进行25分钟的肾蒂阻断,并在单独缺血、单独再灌注(0至30分钟、30至60分钟和60至90分钟)、缺血+再灌注或无缺血期间施加高热。与正常体温缺血对照组相比,评估高热对缺血/再灌注腺苷酸池、脂质过氧化(丙二醛)和ARF严重程度的影响。局限于缺血期的高热会显著加重ARF,而在即刻再灌注(0至30分钟)期间,高热仅有轻微的ARF增强作用。在后期再灌注(大于30分钟)或无缺血情况下,高热不会造成损害。高热对缺血ATP含量仅有短暂的负面影响,仅在缺血的前5分钟略微降低。然而,导致了更严重的缺血损伤,表现为血管阻断结束时近端肾小管刷状缘膜脱落增加。仅在再灌注期间施加的高热不影响ATP浓度。由于ATP降解增加,高热使缺血末期嘌呤碱浓度增加了10%。然而,再灌注脂质过氧化并未发生,黄嘌呤氧化酶抑制(通过氧嘌呤醇)也未提供保护。
(a)高热主要通过影响缺血损伤而非再灌注损伤来加重ARF;(b)黄嘌呤氧化酶不是高热缺血性ARF的重要介导因素;(c)高热对缺血ATP水平的影响在数量上微不足道。这表明高热主要通过放大能量消耗的后果(如膜损伤)而非本身加重能量消耗来加重ARF。